STOCK TITAN

Investor Notice: Lawsuit for Investors who Lost over $50,000 in Acutus Medical, Inc shares announced by Shareholders Foundation

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Negative)
Tags

SAN DIEGO, March 15, 2022 /PRNewswire/ -- The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in Acutus Medical, Inc. (NASDAQ: AFIB) shares.

Investors who have losses of over $50,000 from their investment in shares of Acutus Medical, Inc. (NASDAQ: AFIB) have certain options and there are short and strict deadlines running. Deadline: April 18th, 2022. NASDAQ: AFIB investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

On February 15, 2022, a lawsuit was filed against Acutus Medical, Inc. over alleged Securities Laws Violations. The plaintiff alleges that Acutus Medical made false and misleading statements and failed to disclose that a material percentage of the AcQMap systems under evaluation had been randomly installed at sites with little, if any, consideration given to whether the healthcare providers at the selected locations were likely to adopt, or desire, Acutus Medical's products, that a material percentage of the AcQMap systems under evaluation had been installed in locations where Acutus Medical did not possess the infrastructure necessary to appropriately educate, train, and support medical service providers on the system's operations, that as a result, Acutus Medical was in the process of designing a strategic plan to terminate and relocate approximately 20% of then-existing AcQMap systems evaluation arrangements, that Acutus Medical's management discussion and analysis was materially false and misleading and failed to disclose that the termination and relocation of approximately 20% of existing AcQMap systems evaluation arrangements was reasonably likely to have a material adverse effect on Acutus Medical's 2021 financial results, and that Acutus Medical's risk factor discussions were materially false and misleading and made reference to potential risks without disclosing that such risks were then-existing or adequately describing the specific nature of the risks then facing Acutus Medical.

Those who purchased shares of Acutus Medical, Inc. (NASDAQ: AFIB) should contact the Shareholders Foundation, Inc.

CONTACT:
Shareholders Foundation, Inc. 
Michael Daniels 
+1 (858) 779-1554 
mail@shareholdersfoundation.com 
3111 Camino Del Rio North 
Suite 423 
San Diego, CA 92108

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/investor-notice-lawsuit-for-investors-who-lost-over-50-000-in-acutus-medical-inc-shares-announced-by-shareholders-foundation-301502649.html

SOURCE Shareholders Foundation, Inc.

Acutus Medical, Inc.

OTC:AFIB

AFIB Rankings

AFIB Latest News

AFIB Stock Data

1.77M
23.42M
3.61%
23.55%
2.84%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
CARLSBAD

About AFIB

world class talent with the mission to reshape ep acutus medical has attracted some of the most respected pioneers and leaders in electrophysiology and cardiac device manufacturing to join our organization and our worldwide network of collaborative partners. the common bond that brings us together is our passion and collective capability to revolutionize a field that has not seen major technological advances in decades. our mission of continual innovation is focused on providing electrophysiologists with the highest quality suite of tools, coupled with outstanding clinical and technical support, to better understand and effectively treat complex arrhythmias. electrophysiology is a high growth market with a clear need for a leap-frog technology to address the unmet need for a scientific, medical evidence-based approach to treating atrial fibrillation, ventricular tachycardia and the other complex arrhythmia's. acutus medical is a full-portfolio solution provider for treating these patie